Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vioguard is a medical technology company focused on developing automated UV-C disinfection solutions to combat healthcare-associated infections (HAIs). The company's primary product line includes the UVKB, an FDA-cleared self-disinfecting keyboard, and the UV-C Disinfecting Cubby, designed for rapid sanitization of mobile devices and tablets. Utilizing high-output UV-C lamps and patented sensor technology, Vioguard's devices provide a 99.99% kill rate against harmful pathogens like Norovirus and MRSA. These solutions are engineered for integration into clinical workflows, ensuring that high-touch surfaces remain sterile without manual intervention. Vioguard serves a global market of hospitals, dental offices, and long-term care facilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vioguard.